Skip to content

EDESA BIOTECH, INC.: 10-Q filed 2018-08-08

What EDESA BIOTECH, INC. reported in its quarterly report filed 2018-08-08 (fiscal Q3 2018): 28 published measures, 74 facts as tagged in accession 0001144204-18-042847.

This filing

Form
10-Q (quarterly report)
Filed
2018-08-08
Fiscal period
fiscal Q3 2018
Accession
0001144204-18-042847 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EDESA BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-06-3012,801,300USD
At 2017-09-307,720,005USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-06-3012,386,690USD
At 2017-09-307,399,058USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-06-305,820,582USD
At 2017-09-304,570,951USD
At 2017-06-303,647,363USD
At 2016-09-307,416,904USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-1,156,672USD91
2017-10-01 to 2018-06-30-3,909,945USD273
2017-04-01 to 2017-06-30-1,220,361USD91
2016-10-01 to 2017-06-30-3,809,710USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-10-01 to 2018-06-30-3,644,272USD273
2016-10-01 to 2017-06-30-3,582,534USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-10-01 to 2018-06-30361,400USD273
2016-10-01 to 2017-06-30200,365USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-04-01 to 2018-06-3073,053USD91
2017-10-01 to 2018-06-30157,592USD273
2017-04-01 to 2017-06-3020,532USD91
2016-10-01 to 2017-06-30225,407USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-10-01 to 2018-06-308,772,167USD273
2016-10-01 to 2017-06-300USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-10-01 to 2018-06-30-3,830,553USD273
2016-10-01 to 2017-06-30-209,218USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-06-30-49,301,988USD
At 2017-09-30-45,392,043USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-04-01 to 2018-06-300USD91
2017-10-01 to 2018-06-30800USD273
2017-04-01 to 2017-06-300USD91
2016-10-01 to 2017-06-30800USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-06-301,085,575USD
At 2017-09-30879,523USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-10-01 to 2018-06-30125,409USD273
2016-10-01 to 2017-06-3092,480USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-1,158,401USD91
2017-10-01 to 2018-06-30-3,892,137USD273
2017-04-01 to 2017-06-30-1,293,616USD91
2016-10-01 to 2017-06-30-3,855,649USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-06-3011,633,690USD
At 2017-09-306,758,447USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-06-30414,610USD
At 2017-09-30320,947USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,231,454USD91
2017-10-01 to 2018-06-304,049,729USD273
2017-04-01 to 2017-06-301,314,148USD91
2016-10-01 to 2017-06-304,081,056USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2018-06-30237,494USD
At 2017-09-3068,114USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-04-01 to 2018-06-30465,180USD91
2017-10-01 to 2018-06-301,590,087USD273
2017-04-01 to 2017-06-30536,169USD91
2016-10-01 to 2017-06-301,326,405USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-06-305,330,715shares
At 2017-09-301,502,870shares

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-06-301,101,776USD
At 2017-09-30969,418USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-04-01 to 2018-06-30651,166USD91
2017-10-01 to 2018-06-302,103,636USD273
2017-04-01 to 2017-06-30635,716USD91
2016-10-01 to 2017-06-302,314,143USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-10-01 to 2018-06-30142,643USD273
2016-10-01 to 2017-06-30135,515USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,729USD91
2017-10-01 to 2018-06-30-17,008USD273
2017-04-01 to 2017-06-3073,255USD91
2016-10-01 to 2017-06-3046,739USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-10-01 to 2018-06-30800USD273
2016-10-01 to 2017-06-30800USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-10-01 to 2018-06-304,520,319USD273
2016-10-01 to 2017-06-300USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-10-01 to 2018-06-309,080USD273
2016-10-01 to 2017-06-30-73,906USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-10-01 to 2018-06-30169,380USD273
2016-10-01 to 2017-06-30-108,483USD273

Inspect the source

Entity
EDESA BIOTECH, INC. / CIK 0001540159
Captured
2026-09-20T09:17:32.413Z
SEC response SHA-256
0f44de1ccf1eff46a1af17dc21d4a3bb38216bbf46e813f5a136d29e08bfd65d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001540159.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))